Momenta Pharmaceuticals (MNTA) Replaces HealthSpring (HS) in S&P SmallCap 600
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Join SI Premium – FREE
After the close Friday, S&P announced that Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) will replace HealthSpring, Inc. (NYSE: HS) in the S&P SmallCap 600 index after the close of trading on Tuesday, January 31.
Cigna Corp. (NYSE: CI) is acquiring HealthSpring in a deal expected to be completed on January 30.
Cigna Corp. (NYSE: CI) is acquiring HealthSpring in a deal expected to be completed on January 30.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Home Depot expands executive roles, grants $500K in restricted stock
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
Create E-mail Alert Related Categories
Corporate News, Trader TalkRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
